The Latest Breaking News from Pfizer

The stock market has witnessed significant volatility amid the record high inflation and the Fed’s hawkish stance on it. Investors have been banking on healthcare stocks as they tend to hold up relatively well in such turbulent times. We think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer…

Government health officials said Tuesday that, unless another variant emerges, it’s likely that coronavirus boosters will become a yearly thing, much like flu shots.

Company says scheme will boost minority representation

US president and first lady have both reported relapses after using drug to treat coronavirus

Federal cannabis legalization might reduce conventional pharmaceutical sales by billions of dollars according to a new study cond

New COVID-19 boosters targeting today’s most common omicron strains should begin arriving within days

Social media users shared a range of false claims this week

The European Medicines Agency (EMA) has backed two separate Covid-19 booster vaccines updated to target the omicron variant of Covid-19 and developed by drugmakers Moderna and BioNTech-Pfizer.

DENVER — COVID-19 booster shots with a new omicron-targeting recipe are expected to arrive in pharmacies and clinics next week, but the experience of getting them will be largely the same as previous rounds of the vaccine.

Denmark is preparing to go through the coming winter without any coronavirus restrictions even with an expected rise in infections, Health Minister Magnus Heunicke said on Friday.

People can get the Moderna booster if they're 18 or older, and the Pfizer-BioNTech version if they're 12 and up. In both cases, they must wait at least two months since their last COVID vaccine.